Assignee
CHRYSALIS PHARMA AG
CH·4 granted patents·3 pending applications·18 citations·filing 2011–2019
Top patents by PatentIndex Score
7 records- 0187US9012501B2Type A gelatin capsule containing PUFA in free acid formCHRYSALIS PHARMA AG·Filed 2013·Granted Apr 21, 2015·8 cites·20 claims
- 0287US8383678B2Type a gelatin capsule containing PUFA in free acid formCHRYSALIS PHARMA AG·Filed 2011·Granted Feb 26, 2013·9 cites·20 claims
- 0372US9132112B2Type A gelatin capsule containing PUFA in free acid formCHRYSALIS PHARMA AG·Filed 2014·Granted Sep 15, 2015·1 cites·37 claims
- 0458US2017056354A1Type a gelatin capsule containing pufa in free acid formCHRYSALIS PHARMA AG·Filed 2016·Application pending·0 cites
- 0553US2015238430A1Pharmaceutical compositionCHRYSALIS PHARMA AG·Filed 2015·Application pending·0 cites
- 0637US10314789B2Soft gelatin encapsulated pharmaceutical composition of cis-5,8,11,14,17-eicosapentaenoic acid in free acid form and cis-7,10,13,16,19-docosapentaenoic acid in free acid formCHRYSALIS PHARMA AG·Filed 2013·Granted Jun 11, 2019·0 cites·11 claims
- 0733US2019167599A1Soft gelatin encapsulated pharmaceutical composition of cis-5,8,11,14,17-eicosapentaenoic acid in free acid form and cis-7,10,13,16,19-docosapentaenoic acid in free acid formCHRYSALIS PHARMA AG·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →